Effect of iron containing phosphate binder on iron metabolism of patients undergoing maintenance hemodialysis.
Latest Information Update: 06 Oct 2016
Price :
$35 *
At a glance
- Drugs Sucroferric oxyhydroxide (Primary)
- Indications Renal failure
- Focus Adverse reactions
- 06 Oct 2016 New trial record